144 related articles for article (PubMed ID: 21277684)
1. Gene profiling in breast cancer: time to move forward.
Espinosa E; Vara JÁ; Navarro IS; Gámez-Pozo A; Pinto A; Zamora P; Redondo A; Feliu J
Cancer Treat Rev; 2011 Oct; 37(6):416-21. PubMed ID: 21277684
[TBL] [Abstract][Full Text] [Related]
2. Prognostic applications of gene expression signatures in breast cancer.
Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
[TBL] [Abstract][Full Text] [Related]
3. The present and future of gene profiling in breast cancer.
Espinosa E; Gámez-Pozo A; Sánchez-Navarro I; Pinto A; Castañeda CA; Ciruelos E; Feliu J; Vara JA
Cancer Metastasis Rev; 2012 Jun; 31(1-2):41-6. PubMed ID: 22124734
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling in breast cancer: towards individualising patient management.
Murphy N; Millar E; Lee CS
Pathology; 2005 Aug; 37(4):271-7. PubMed ID: 16194824
[TBL] [Abstract][Full Text] [Related]
5. Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel.
Kaufmann M; Pusztai L;
Cancer; 2011 Apr; 117(8):1575-82. PubMed ID: 21472705
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling in breast cancer.
Morris SR; Carey LA
Curr Opin Oncol; 2007 Nov; 19(6):547-51. PubMed ID: 17906450
[TBL] [Abstract][Full Text] [Related]
7. Genomic strategies for personalized cancer therapy.
Garman KS; Nevins JR; Potti A
Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
[TBL] [Abstract][Full Text] [Related]
8. Review of gene-expression profiling and its clinical use in breast cancer.
Stadler ZK; Come SE
Crit Rev Oncol Hematol; 2009 Jan; 69(1):1-11. PubMed ID: 18614375
[TBL] [Abstract][Full Text] [Related]
9. When will tumor gene expression profiling be incorporated into clinical breast cancer decision making?
Creighton CJ; Rae JM
Breast Cancer Res; 2006; 8(4):302. PubMed ID: 16834787
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
11. Current status of prognostic profiling in breast cancer.
Pusztai L
Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
[TBL] [Abstract][Full Text] [Related]
12. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
[TBL] [Abstract][Full Text] [Related]
13. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
14. Critical review of microarray-based prognostic tests and trials in breast cancer.
Koscielny S
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):47-50. PubMed ID: 18197005
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic classification of breast cancer and gene expression profiling].
Bertucci F; Finetti P; Cervera N; Birnbaum D
Med Sci (Paris); 2008; 24(6-7):599-606. PubMed ID: 18601877
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling in breast cancer.
Nasser SM
J Med Liban; 2009; 57(2):83-8. PubMed ID: 19623883
[TBL] [Abstract][Full Text] [Related]
17. [Histopathologic diagnosis of luminal and basal type breast cancer].
Sarcević B
Acta Med Croatica; 2008 Oct; 62(4):427-30. PubMed ID: 19205420
[TBL] [Abstract][Full Text] [Related]
18. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F; Reis-Filho JS
Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
[TBL] [Abstract][Full Text] [Related]
19. [Gene expression profiling of ER+ breast cancers: to discriminate the poor prognosis tumors or to define the most suitable treatment?].
Chanrion M; Darbon JM
Bull Cancer; 2008 May; 95(5):513-8. PubMed ID: 18541515
[TBL] [Abstract][Full Text] [Related]
20. Regulating diagnosis in post-genomic medicine: re-aligning clinical judgment?
Bourret P; Keating P; Cambrosio A
Soc Sci Med; 2011 Sep; 73(6):816-24. PubMed ID: 21664021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
